All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

05:24, 2 December 2023 Larysse talk contribs created page Data Dictionary: National FinHealth 2017 Study (Created page with "Go back to Finland page. Source: []. {| class="wikitable" ! Questionnaires content |- | What is your present state of health? |- | Do you have any longstanding illness or health problem? |- | Are you limited because of a health problem in activities people usually do? What is your limitation level? |- | Have you been limited for at least the past 6 months? |- | Has a doctor diagnosed or treated you for any of the following diseases during the past last 12 months? C...")
04:57, 2 December 2023 Larysse talk contribs created page Data Dictionary: Register of Primary Health Care Visits (Created page with "Go back to Finland page. Source:[https://thl.fi/en/web/thlfi-en/statistics-and-data/data-and-services/register-descriptions/register-of-primary-health-care-visits#data%20content]. {| class="wikitable" ! Data about the service event |- | Client's personal identity number (encrypted in the register) |- | Client's municipality of residence |- | Postcode of the client's place of residence |- | Service provider |- | Service unit of the service provider |- | Event record...")
22:16, 1 December 2023 Francine talk contribs created page Trials (Centre François Baclesse) (Created page with "'''NCTID''': NCT01827943 '''Title''': Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer '''Study Summary''': In the absence of standard treatment in this indication, this test evaluates a new drug type targeted therapy in this indication, evaluating its efficacy in terms of tumor response and survival. '''Sponsor''': Institut Bergonié '''Intervention''': Temsirolimus '''Start Date''': 2009-06 '''Last Updated''...")
22:10, 1 December 2023 Francine talk contribs created page Trials (University Cancer Institute Toulouse-Oncopole) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Institute Toulouse-Oncopole page '''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced mel...")
22:04, 1 December 2023 Francine talk contribs created page Trials (Institut Paoli-Calmettes) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Paoli-Calmettes page '''NCTID''': NCT04070443 '''Title''': Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase '''Study Summary''': The investigators hypothesize that, in newly diagnosed de novo chronic phase CML patients, an induction treatment with ponatinib for 6 months should increase the rate of patients reaching a stable...")
21:58, 1 December 2023 Francine talk contribs created page Trials (Institut Curie) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Curie page '''NCTID''': NCT03875573 '''Title''': Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: '''Study Summary''': Neo-CheckRay is a multicenter, open-label phase II study that randomizes luminal B breast cancer subjects candidate for neo-adjuvant chemotherapy in a 1:1:1 ratio in 3 arms:...")
21:52, 1 December 2023 Francine talk contribs created page Trials (Léon Bérard Center) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Léon Bérard Center page '''NCTID''': NCT01222767 '''Title''': Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy '''Study Summary''': This is a phase II Multicenter, Open-label, Clinical and Pharmacokinetic Study of Zalypsis® (PM00104) in Patients with Unresectable Loc...")
21:28, 1 December 2023 Francine talk contribs created page Trials (Oulu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Oulu University Hospital page '''NCTID''': NCT04607421 '''Title''': A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer '''Study Summary''': The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal c...")
21:22, 1 December 2023 Francine talk contribs created page Trials (Cancer Center of Kuopio University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Cancer Center of Kuopio University Hospital page '''NCTID''': NCT04597125 '''Title''': Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH '''Study Summary''':...")
21:17, 1 December 2023 Francine talk contribs created page Trials (TAYS Cancer Centre Tampere University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to TAYS Cancer Centre Tampere University Hospital page '''NCTID''': NCT04736706 '''Title''': A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) '''Study Summary''': The goal of...")
21:11, 1 December 2023 Francine talk contribs created page Trials (Turku University Hospital Cancer Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Turku University Hospital Cancer Centre page '''NCTID''': NCT03486873 '''Title''': Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) '''Study Summary''': The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in part...")
21:03, 1 December 2023 Francine talk contribs created page Trials (Institut Jules Bordet) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Jules Bordet page '''NCTID''': NCT04966715 '''Title''': Inferior Epigastric Lymph Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Colorectal Peritoneal Metastases '''Study Summary''': In this study, the investigators propose to systematically collect and analyse epigastric lymph nodes during complete cytureductive surgery in patients with colorectal carcinomatosis, in order to d...")
20:55, 1 December 2023 Francine talk contribs created page Trials (Masaryk Memorial Cancer Institute) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Masaryk Memorial Cancer Institute page '''NCTID''': NCT05603351 '''Title''': Prostate Cancer Screening With Abbreviated MRI Protocol '''Study Summary''': Prostate cancer is one of the most common malignancies in the male population with incidence and mortality rates comparable to breast cancer in women, but in contrast, a population screening program that would fulfill all the recommended criteria is n...")
20:52, 1 December 2023 Francine talk contribs created page Trials (Motol University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Motol University Hospital page '''NCTID''': NCT02447666 '''Title''': Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML) '''Study Summary''': Indication Treatment of pediatric subjects with newly diagnosed advanced myelodysplastic syndrome (MDS) or juvenile myelomonocytic leukemia (JMML) prior to hematop...")
20:50, 1 December 2023 Francine talk contribs created page Trials (Vejle Cancer Centre - The Patients’ Cancer Hospital part of Lillebaelt Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Vejle Cancer Centre – The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered...")
20:49, 1 December 2023 Francine talk contribs created page Trials (The Patients’ Cancer Hospital part of Lillebaelt Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to The Patients’ Cancer Hospital part of Lillebaelt Hospital page '''NCTID''': NCT05573022 '''Title''': Impact of a Patient Decision Aid Intervention '''Study Summary''': Studies evaluating decisions aids have used a wide range of outcome measures as well as formats and settings. Most studies have focused on patient decision aids used either within the consultation or delivered pre-consultation, but t...")
20:47, 1 December 2023 Francine talk contribs created page Trials (Tartu University Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Tartu University Hospital page '''NCTID''': NCT04241185 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) '''Study Summary''': This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT a...")
20:45, 1 December 2023 Francine talk contribs created page Trials (North Estonia Medical Centre) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to North Estonia Medical Centre '''NCTID''': NCT02205047 '''Title''': Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma '''Study Summary''': The purpose of this study is to find out whether either trastuzumab or the combination of trastuzumab and pertuzumab with standard chemotherapy shows more activity against gastro-oesophageal aden...")
20:39, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:38, 1 December 2023 Francine talk contribs created page Trials (East Tallinn Central Hospital Trials) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to East Tallinn Central Hospital Trials page '''NCTID''': NCT05152147 '''Title''': A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers '''Study Summary''': This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better t...")
20:05, 1 December 2023 Francine talk contribs created page Trials (Helsinki University Hospital Comprehensive Cancer Center) (Created page with "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: * is advanced or metastatic (spread to other parts of the body); * has a certain type of abnormal...")
19:02, 1 December 2023 Larysse talk contribs created page Data Dictionary: FINRISK (Created page with "Go back to Finland page. {| class="wikitable" ! Variable !! Field Description |- | FR12_2 || Marital status |- | FR02_3 || Education |- | KOULV || Number of years of education |- | K13 || Number of persons in household |- | K14A || Number of persons in household under the age of 7 |- | K14B || Number of persons in household aged between 7 and 16 |- | TULOT || Household incomes |- | AMM || Occupation |- | IKA10 || 10 year age groups |- | IKA || Age =...")
18:06, 30 November 2023 Francine talk contribs created page Trials (Kortrijk Cancer Centre AZ Groeninge) (Created page with "{{forresearchers}} Go back to Kortrijk Cancer Centre AZ Groeninge page Kortrijk Cancer Centre AZ Groeninge Trials")
13:21, 30 November 2023 Victor talk contribs created page Template:Forproviders (Created page with "Category:forproviders")
13:20, 30 November 2023 Victor talk contribs created page Template:Forpolicymakers (Created page with "Category:forpolicymakers")
13:20, 30 November 2023 Victor talk contribs created page Template:Forresearchers (Created page with "Category:forresearchers")
03:26, 30 November 2023 Woloski talk contribs created page Fondazione I.R.C.C.S. Policlinico San Matteo Trials (Created page with "'''NCTID''': NCT05210790 '''Title''': A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera '''Study Summary''': The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV. '''Sponsor''': Protagonist Therapeutics, Inc. '''Intervention''': Placebo '''Start Date''': 2022-04-01 '''Last Updated''': 2023-11-09 '''Number of Patients''': 250...")
03:23, 30 November 2023 Woloski talk contribs created page Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano Trials (Created page with "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages. Clinical studies and real-world data show that the use of Patient Reported Outcome Measures (PR...")
03:17, 30 November 2023 Woloski talk contribs created page Fondazione Policlinico Universitario Agostino Gemelli IRCCS Trials (Created page with "'''NCTID''': NCT05323656 '''Title''': A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) '''Study Summary''': The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version 1.1 (RECIST v1.1) in recurrent or metastatic SCCHN patients treated with setanaxib and pembrolizumab versus patients treated with pl...")
03:14, 30 November 2023 Woloski talk contribs created page IRCCS - Romagna Institute for the Study of Cancer 'Dino Amadori' Trials (Created page with "'''NCTID''': NCT04775290 '''Title''': Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy '''Study Summary''': The study aims to investigate, through serial measurements of some biomarkers, the potential mechanisms through which yoga impacts on QOL and fatigue. '''Sponsor''': Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori '''Intervention''': Yoga lessons '''Start Date''': 2019-08-02...")
03:09, 30 November 2023 Woloski talk contribs created page Sacro Cuore - Don Calabria Hospital Trials (Created page with "'''NCTID''': NCT01940497 '''Title''': A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer '''Study Summary''': This non-randomized, multicenter, open-label study will assess the safety and efficacy of subcutaneously administered trastuzumab in participants with early and locally advanced HER2-positive breast cancer in two seq...")
03:05, 30 November 2023 Woloski talk contribs created page Mediterranean Institute of Oncology Trials (Created page with "'''NCTID''': NCT06008691 '''Title''': A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice '''Study Summary''': This is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (NHL) in Italian clinical practice. '''Sponsor''': Fondazione Italiana Linfomi - ETS '''Intervention''...")
03:02, 30 November 2023 Woloski talk contribs created page Candiolo Cancer Institute Trials (Created page with "'''NCTID''': NCT04296890 '''Title''': A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression '''Study Summary''': This study is designed to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with platinum-resistant high-grade serous epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, w...")
02:59, 30 November 2023 Woloski talk contribs created page Ospedale San Raffaele Trials (Created page with "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients...")
02:55, 30 November 2023 Woloski talk contribs created page IRCCS Centro di Riferimento Oncologico della Basilicata Trials (Created page with "'''NCTID''': NCT03268954 '''Title''': Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) '''Study Summary''': The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared with single-agent azaci...")
02:48, 30 November 2023 Woloski talk contribs created page Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico Trials (Created page with "'''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced terminal stages. Clinical studies and real-world data show that the use of Patient Reported Outcome Measures (PR...")
02:09, 30 November 2023 Woloski talk contribs created page Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia Trials (Created page with "'''NCTID''': NCT05929222 '''Title''': Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi '''Study Summary''': Prospective, multicenter, open label, phase III randomized clinical trial in previously untreated Follicular Lymphoma in early stage. Patients will be randomized to receive Radiotherapy or Radiotherapy plus Obinotuzumab. '''Sponsor''': Fondazione...")
02:05, 30 November 2023 Woloski talk contribs created page Istituto Nazionale Tumori -IRCCS 'Fondazione G.Pascale' Trials (Created page with "'''NCTID''': NCT03771456 '''Title''': Anastomotic Leakage and Enhanced Recovery Pathways After Colorectal Surgery '''Study Summary''': Prospective observational multicenter study on the influence of adherence to enhanced recovery pathways on early outcomes (anastomotic leakage, morbidity, mortality, readmission, reoperation rates and length of postoperative stay) after elective colorectal surgery in Italy. '''Sponsor''': Ospedale C & G Mazzoni '''Intervention...")
02:00, 30 November 2023 Woloski talk contribs created page Humanitas Research Hospital Trials (Created page with "'''NCTID''': NCT04800497 '''Title''': The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC '''Study Summary''': Hepatocellular carcinoma (HCC) recurs in up to 60% of patients who undergo resection. Circulating tumor cells (CTC) have been advocated as promotors of the recurrence. However, their role as prognostic markers in the surgical setting is unclear. The aim of the present study has been to assess the association between CTC fr...")
01:29, 30 November 2023 Woloski talk contribs created page Istituto Oncologico Veneto IRCCS-IOV Trials (Created page with "'''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients...")
01:25, 30 November 2023 Woloski talk contribs created page Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano Trials (Created page with "'''NCTID''': NCT05594290 '''Title''': Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery '''Study Summary''': This is a window-of-opportunity study for patients with resectable Merkel Cell Carcinoma. The aim of this study is to test the activity of a course of chemo-immunotherapy followed by surgery in patients with operable Merkel cell carcinoma. Participants will receive one cycle of retifanlimab plus platinum-etoposide chemoth...")
01:22, 30 November 2023 Woloski talk contribs created page European Institute of Oncology Trials (Created page with "'''NCTID''': NCT05554003 '''Title''': Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study '''Study Summary''': Study design and rationale: Neuroendocrine neoplasms (NENs ) represent a heterogeneous group of malignancies, which differ in terms of behavio r and prognosis. Most of t hem are advanced at diagnosis t herefore systemic treatment is proposed. While over the last ye...")
01:18, 30 November 2023 Woloski talk contribs created page IRCCS Ospedale Policlinico San Martino Trials (Created page with "'''NCTID''': NCT05291156 '''Title''': CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy '''Study Summary''': This is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated RAS/BRAF wild type metastatic colorectal cancer patients (according to liquid biopsy at baseline). Patients have been treated in first...")
01:12, 30 November 2023 Woloski talk contribs created page Centro di Riferimento Oncologico di Aviano Trials (Created page with "'''NCTID''': NCT00002903 '''Title''': Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer '''Study Summary''': RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with recurrent or refractory germ cell cancer. '''Sponsor''': European Organisation for Research and Treatment of Cancer - EORT...")
01:09, 30 November 2023 Woloski talk contribs created page Rijnstate Trials (Created page with "'''NCTID''': NCT00091156 '''Title''': Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer '''Study Summary''': RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. It is not yet known whether giving gefitinib after initial chemotherapy is effective in delaying the recurrence of non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying ge...")
01:07, 30 November 2023 Woloski talk contribs created page Radboudumc Centre for Oncology Trials (Created page with "'''NCTID''': NCT01322490 '''Title''': A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer '''Study Summary''': The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from metastatic, castrate-resistant prostate cancer. '''Sponsor'''...")
00:51, 30 November 2023 Woloski talk contribs created page Erasmus MC Kanker Instituut Trials (Created page with "'''NCTID''': NCT05208047 '''Title''': (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors '''Study Summary''': This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll approximately 426 patients. Part 1 consists of two evaluations: 1) confirming the dose of an updated formulation of CGT9486 to be used in subse...")
00:48, 30 November 2023 Woloski talk contribs created page University Medical Center Groningen Comprehensive Cancer Center Trials (Created page with "'''NCTID''': NCT03719690 '''Title''': Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy '''Study Summary''': An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). The first cohort will assess the objective response rate (ORR) of tipifarnib in subjects with HNSCC with HRAS mutations. The second study c...")
00:45, 30 November 2023 Woloski talk contribs created page The Maastricht UMC+ Comprehensive Cancer Center Trials (Created page with "'''NCTID''': NCT02968303 '''Title''': Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy '''Study Summary''': Rationale: The combination of ipilimumab and nivolumab induces relatively high response rates and promising response depth in late stage melanoma. Nevertheless, it takes time till responses occur and still a significant number of patients do not benefit from treatment, due to rapid progressive disease or resistanc...")
00:35, 30 November 2023 Woloski talk contribs created page Netherlands Cancer Institute - Antoni van Leeuwenhoek Trials (Created page with "'''NCTID''': NCT04614103 '''Title''': Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer '''Study Summary''': This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer '''Sponsor''': Iovance Biotherapeutics, Inc. '''Intervention''': LN-145 '''Start Date''': 2021-05-07 '''Last Updated''': 2023-10-10 '''Number of Patients''': 170 '...")